Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003459
Filing Date
2025-03-21
Accepted
2025-03-21 16:05:31
Documents
83
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sngx-20241231x10k.htm   iXBRL 10-K 2824511
2 EX-4.1 sngx-20241231xex4d1.htm EX-4.1 34219
3 EX-21.1 sngx-20241231xex21d1.htm EX-21.1 13750
4 EX-23.1 sngx-20241231xex23d1.htm EX-23.1 5256
5 EX-31.1 sngx-20241231xex31d1.htm EX-31.1 10755
6 EX-31.2 sngx-20241231xex31d2.htm EX-31.2 14077
7 EX-32.1 sngx-20241231xex32d1.htm EX-32.1 5959
8 EX-32.2 sngx-20241231xex32d2.htm EX-32.2 5940
9 GRAPHIC sngx-20241231x10k004.jpg GRAPHIC 784
10 GRAPHIC sngx-20241231x10k005.jpg GRAPHIC 796
  Complete submission text file 0001558370-25-003459.txt   10579988

Data Files

Seq Description Document Type Size
11 EX-101.SCH sngx-20241231.xsd EX-101.SCH 72135
12 EX-101.CAL sngx-20241231_cal.xml EX-101.CAL 57732
13 EX-101.DEF sngx-20241231_def.xml EX-101.DEF 265450
14 EX-101.LAB sngx-20241231_lab.xml EX-101.LAB 597977
15 EX-101.PRE sngx-20241231_pre.xml EX-101.PRE 441882
86 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20241231x10k_htm.xml XML 1741448
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14778 | Film No.: 25760469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)